RECRUITING

Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The primary goal of this study is to establish a database of people with varying levels of hepatic fibrosis and various etiologies of liver disease for use in future research protocols.

Official Title

Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database

Quick Facts

Study Start:2016-10-28
Study Completion:2026-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02897908

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Subjects with known, or suspected risk factors for steatosis (fat) or hepatic fibrosis
  2. * Subjects who have been previously diagnosed with Non-Alcoholic Steatohepatitis (NASH) but who do not have current steatosis (fat) or fibrosis scoring
  3. * Subjects who have other known liver diseases ie: HCV
  1. * Patients less than 18 years of age
  2. * Pregnancy
  3. * Patients that do not want to be contacted for consideration in future research studies.
  4. * Patients diagnosed with ascites or peritoneal dialysis
  5. * Body mass index (BMI) ≥40

Contacts and Locations

Study Contact

Ajay Chaudhuri, MD
CONTACT
716-907-1916
achaudhu@buffalo.edu
Andrew Talal, MD
CONTACT
716-888-4737
ahtalal@buffalo.edu

Study Locations (Sites)

Conventus Medical Office Building
Buffalo, New York, 14203
United States

Collaborators and Investigators

Sponsor: State University of New York at Buffalo

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2016-10-28
Study Completion Date2026-12

Study Record Updates

Study Start Date2016-10-28
Study Completion Date2026-12

Terms related to this study

Additional Relevant MeSH Terms

  • Disease of Liver and Bile Duct